JPH04305522A - Application agent for medical use - Google Patents
Application agent for medical useInfo
- Publication number
- JPH04305522A JPH04305522A JP6831491A JP6831491A JPH04305522A JP H04305522 A JPH04305522 A JP H04305522A JP 6831491 A JP6831491 A JP 6831491A JP 6831491 A JP6831491 A JP 6831491A JP H04305522 A JPH04305522 A JP H04305522A
- Authority
- JP
- Japan
- Prior art keywords
- support
- patch
- woven
- nonwoven fabric
- medical use
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000011505 plaster Substances 0.000 claims abstract description 23
- 239000004615 ingredient Substances 0.000 claims abstract description 12
- 239000000853 adhesive Substances 0.000 claims description 27
- 230000001070 adhesive effect Effects 0.000 claims description 27
- 238000005452 bending Methods 0.000 claims description 9
- 230000000694 effects Effects 0.000 abstract description 23
- 230000003285 pharmacodynamic effect Effects 0.000 abstract 1
- 239000010410 layer Substances 0.000 description 37
- 239000004745 nonwoven fabric Substances 0.000 description 36
- 239000006260 foam Substances 0.000 description 27
- 239000002759 woven fabric Substances 0.000 description 22
- 238000000034 method Methods 0.000 description 18
- 239000000835 fiber Substances 0.000 description 12
- 229920005989 resin Polymers 0.000 description 8
- 239000011347 resin Substances 0.000 description 8
- 239000011248 coating agent Substances 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 208000008930 Low Back Pain Diseases 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 238000005187 foaming Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- -1 polyethylene, ethylene-vinyl acetate Polymers 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- 239000004604 Blowing Agent Substances 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229920000297 Rayon Polymers 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 239000012943 hotmelt Substances 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000002964 rayon Substances 0.000 description 3
- KKEYFWRCBNTPAC-UHFFFAOYSA-L terephthalate(2-) Chemical compound [O-]C(=O)C1=CC=C(C([O-])=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-L 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- LVYLCBNXHHHPSB-UHFFFAOYSA-N 2-hydroxyethyl salicylate Chemical compound OCCOC(=O)C1=CC=CC=C1O LVYLCBNXHHHPSB-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 125000002723 alicyclic group Chemical group 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 229940007061 capsicum extract Drugs 0.000 description 2
- 239000001943 capsicum frutescens fruit extract Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- RGOVYLWUIBMPGK-UHFFFAOYSA-N nonivamide Chemical compound CCCCCCCCC(=O)NCC1=CC=C(O)C(OC)=C1 RGOVYLWUIBMPGK-UHFFFAOYSA-N 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000009823 thermal lamination Methods 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- ROGIWVXWXZRRMZ-UHFFFAOYSA-N 2-methylbuta-1,3-diene;styrene Chemical compound CC(=C)C=C.C=CC1=CC=CC=C1 ROGIWVXWXZRRMZ-UHFFFAOYSA-N 0.000 description 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241000086254 Arnica montana Species 0.000 description 1
- 235000015701 Artemisia arbuscula Nutrition 0.000 description 1
- 235000002657 Artemisia tridentata Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- 244000042664 Matricaria chamomilla Species 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 229920003020 cross-linked polyethylene Polymers 0.000 description 1
- 239000004703 cross-linked polyethylene Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229940014259 gelatin Drugs 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229960002389 glycol salicylate Drugs 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 238000007757 hot melt coating Methods 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 229940060184 oil ingredients Drugs 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920000346 polystyrene-polyisoprene block-polystyrene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229920006132 styrene block copolymer Polymers 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229920003051 synthetic elastomer Polymers 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 239000005061 synthetic rubber Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000003856 thermoforming Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
【0001】0001
【産業上の利用分野】本発明は、粘着剤に薬効成分を含
ませてなる膏体層が支持体の片面に設けられて構成され
た医療用貼付剤に関し、さらに詳しくは、腰痛、捻挫、
腱鞘、筋肉痛などに対する消炎や鎮痛に用いられた際に
、患部を固定するコルセット効果を有すると共にフィッ
ト感がよく、保温効果、貼着力および薬効に優れ、さら
にそれ自体の形態の保持効果を有する医療用貼付剤に関
するものである。[Field of Industrial Application] The present invention relates to a medical patch comprising a paste layer made of an adhesive containing a medicinal ingredient on one side of a support.
When used for anti-inflammatory and analgesic treatment of tendon sheaths, muscle pain, etc., it has a corset effect that fixes the affected area, provides a good fit, has excellent heat retention effects, adhesive strength, and medicinal effects, and also has the effect of retaining its own form. This relates to medical patches.
【0002】0002
【従来の技術】従来、この種の医療用貼付剤は、支持体
として、スフモスリン、綿布、ネル、起毛不織布などの
織布ないし不織布や、薄いフィルムが用いられ、粘着剤
に薬効成分を含ませてなる膏体層が該支持体の片面に設
けられることにより構成されている。[Prior Art] Conventionally, this type of medical patch uses a woven or non-woven fabric such as sfumuslin, cotton cloth, flannel, or raised non-woven fabric, or a thin film as a support, and has an adhesive containing a medicinal ingredient. It is constructed by providing a plaster layer consisting of a material on one side of the support.
【0003】これらの織布、不織布またはフィルムから
なる支持体は、貼付剤を体の動きに追従せしめ、貼付部
に違和感を与えないことを狙って、良好な保温性、通気
性、吸水性を有し、かつ薄くてしなやかで伸縮性のある
貼付剤を指向したものである。そのため、市販の貼付剤
の支持体は、たとえばJIS L 1005による剛軟
度が17〜28mm程度の織布または不織布からなるも
のである。[0003] These supports made of woven fabrics, non-woven fabrics, or films have good heat retention, breathability, and water absorption properties so that the patch can follow the movements of the body and do not cause discomfort at the application site. The aim is to create a patch that is thin, flexible, and stretchable. Therefore, the support of commercially available patches is made of woven or nonwoven fabric having a bending resistance of about 17 to 28 mm according to JIS L 1005, for example.
【0004】0004
【発明が解決しようとする課題】しかし、上記のような
材料からなる支持体を用いた従来の医療用貼付剤は、患
部を固定ないしは支える機能を有するものではない。[Problems to be Solved by the Invention] However, conventional medical patches using supports made of the materials described above do not have the function of fixing or supporting the affected area.
【0005】また、こうした構成の貼付剤はいわゆる腰
がなくそれ自体の形態を保持できない。そのため、貼付
の際に剥離紙除去後の貼付剤が膏体面を合わせるように
折れ曲がり、膏体面どうしがくっつくという難点がある
。特に腰痛の場合は患部は腰部背面であるので、貼付位
置合わせがやりにくく、貼付は使用者ひとりでは困難で
ある。[0005] Furthermore, a patch having such a structure has so-called stiffness and cannot maintain its own shape. Therefore, there is a problem in that during application, the patch after the release paper is removed is bent so that the plaster surfaces align, causing the plaster surfaces to stick together. Particularly in the case of lower back pain, since the affected area is the back of the lower back, it is difficult to align the application position and it is difficult for the user to apply it alone.
【0006】本発明の目的とするところは、従来の医療
用貼付剤の上記のような狙いとはむしろ逆であって、患
部を固定するコルセット効果を有すると共にフィット感
がよく、保温効果、貼着力および薬効に優れ、さらにそ
れ自体の形態の保持効果を有する医療用貼付剤を提供す
るにある。The purpose of the present invention is rather the opposite of the above-mentioned aims of conventional medical patches, and is to have a corset effect to fix the affected area, a good fit, a heat retention effect, and a patch. It is an object of the present invention to provide a medical patch that has excellent adhesion and medicinal efficacy, and also has the effect of retaining its own form.
【0007】[0007]
【課題を解決するための手段】本発明は上記目的を達成
すべく工夫されたもので、支持体として特定の物性を有
するものを用いることによって、上記のようなコルセッ
ト効果その他の顕著な効果を発揮させることができると
いう知見を得て完成されたものである。[Means for Solving the Problems] The present invention has been devised to achieve the above object, and by using a material having specific physical properties as a support, it is possible to achieve the above-mentioned corset effect and other remarkable effects. This was completed after gaining knowledge that it could be used to its full potential.
【0008】すなわち、本発明による医療用貼付剤は、
粘着剤に薬効成分を含ませてなる膏体層が、JIS L
1005による剛軟度50mm以上で厚み0.2〜7
mmの支持体の片面に設けられ、支持体側を内側にして
湾曲されていることを特徴とするものである。[0008] That is, the medical patch according to the present invention has the following features:
The plaster layer made of adhesive containing medicinal ingredients is JIS L
1005 with bending resistance of 50 mm or more and thickness of 0.2 to 7
It is characterized in that it is provided on one side of a support body of mm in diameter and is curved with the support side facing inward.
【0009】以下、本発明による医療用貼付剤を構成す
る各成分および同貼付剤の製造法について説明する。[0009] The components constituting the medical patch according to the present invention and the method for producing the patch will be explained below.
【0010】1) 支持体
支持体は、発泡体層と、同層の片面に積層された織布ま
たは不織布とからなるか、もしくは織布または不織布の
みからなる。いずれの場合も、支持体は、JISL 1
005による剛軟度(45°カンチレバー法)が50m
m以上でかつ厚みが0.2〜7mmのものである。1) Support The support consists of a foam layer and a woven or nonwoven fabric laminated on one side of the same layer, or only of the woven or nonwoven fabric. In either case, the support is JISL 1
Bending resistance (45° cantilever method) according to 005 is 50m
m or more and has a thickness of 0.2 to 7 mm.
【0011】JIS L 1005による剛軟度は、温
度23℃、相対湿度65%の条件で、25mm幅×15
0mm長の試験片を、先端部に45°の斜面を有する滑
らかな水平台上から斜面方向に押し出し、試料の先端が
斜面と接した時、その押し出された距離で表わされる。
この値が50mm未満の場合には、しなやかで患部を固
定ないしは支えている感じが低下する。したがって、発
泡体層の剛軟度は50mm以上に限定される。特に好ま
しい剛軟度は100mm以上である。[0011] The bending resistance according to JIS L 1005 is 25 mm width x 15 at a temperature of 23°C and a relative humidity of 65%.
A 0 mm long test piece is pushed out in the direction of the slope from a smooth horizontal table with a 45° slope at the tip, and when the tip of the sample comes into contact with the slope, it is expressed as the distance pushed out. If this value is less than 50 mm, the feeling of pliability and fixing or supporting the affected area will be reduced. Therefore, the bending resistance of the foam layer is limited to 50 mm or more. A particularly preferable bending resistance is 100 mm or more.
【0012】支持体の厚みは0.2〜7mmの範囲であ
る。その理由は、0.2mmよりも薄いと保温性やコル
セット効果が少なく、7mmを超えるとコルセット効果
はよいが違和感が大きくなり、また貼付部分が目立つか
らである。支持体の特に好ましい厚みは1〜3mmの範
囲である。[0012] The thickness of the support is in the range of 0.2 to 7 mm. The reason for this is that if it is thinner than 0.2 mm, the heat retention and corset effect will be low, and if it exceeds 7 mm, the corset effect will be good but it will feel uncomfortable and the attached part will be noticeable. A particularly preferred thickness of the support is in the range of 1 to 3 mm.
【0013】また、支持体の20%モジュラスは0.7
kg/25mm幅以上であり、好ましくは1.0kg/
25mm幅以上である。[0013] Also, the 20% modulus of the support is 0.7
kg/25mm width or more, preferably 1.0 kg/
The width is 25 mm or more.
【0014】(a) 支持体の必須構成部材である織布
または不織布については、織布として、綿、スフ、ナイ
ロン、レーヨンなどの繊維の織布が用いられ、織り方、
密度、繊維デニールなどは特に限定されない。(a) Regarding the woven fabric or non-woven fabric that is an essential component of the support, woven fabrics of fibers such as cotton, cotton, nylon, and rayon are used, and the weaving method,
Density, fiber denier, etc. are not particularly limited.
【0015】不織布としては、レーヨン、セルロース、
ナイロン、ポリプロピレン、ポリエチレングリコールテ
レフタレートなどの繊維の単独またはこれらの混抄品が
使用できる。不織布の繊維は短繊維でも長繊維でもよい
。不織布にはフェルトも含まれる。織布および不織布の
重量は好ましくは15g〜150g/m2 の範囲であ
り、通常40〜70g/m2 のものが適当である。[0015] Nonwoven fabrics include rayon, cellulose,
Fibers such as nylon, polypropylene, and polyethylene glycol terephthalate may be used alone or in combination with these fibers. The fibers of the nonwoven fabric may be short fibers or long fibers. Nonwoven fabrics also include felt. The weight of the woven fabric and nonwoven fabric is preferably in the range of 15 to 150 g/m2, and usually 40 to 70 g/m2.
【0016】発泡体層に貼り合わせる織布または不織布
の厚みは好ましくは0.1〜0.3mmである。[0016] The thickness of the woven fabric or nonwoven fabric bonded to the foam layer is preferably 0.1 to 0.3 mm.
【0017】(b) 支持体の任意付加的構成部材であ
る発泡体層を製造するための樹脂としては、ポリエチレ
ン、エチレン−酢酸ビニル共重合体、ポリウレタン、ポ
リプロピレン、ポリ塩化ビニルなどが例示される。これ
らの樹脂としては架橋タイプおよび非架橋タイプとも使
用可能であるが、架橋タイプの樹脂が望ましい。これら
樹脂から発泡体を得るには、樹脂に発泡剤、架橋剤(放
射線架橋の場合には不用)、必要に応じて多官能性モノ
マーなどを添加し、混合物を所要の形状に成形し、放射
線照射または発泡剤の分解温度以下の温度での加熱によ
って架橋を行ない、ついで発泡剤の分解温度以上の温度
での加熱によって発泡を行なうか架橋と発泡を同時に行
なうなどの方法が採られる。(b) Examples of the resin for producing the foam layer, which is an optional additional component of the support, include polyethylene, ethylene-vinyl acetate copolymer, polyurethane, polypropylene, polyvinyl chloride, etc. . Although both crosslinked and non-crosslinked resins can be used, crosslinked resins are preferred. To obtain foam from these resins, a blowing agent, a crosslinking agent (not needed in the case of radiation crosslinking), a polyfunctional monomer as necessary, etc. are added to the resin, the mixture is molded into the desired shape, and the Methods such as crosslinking is performed by irradiation or heating at a temperature below the decomposition temperature of the blowing agent, and then foaming is performed by heating at a temperature above the decomposition temperature of the blowing agent, or crosslinking and foaming are performed simultaneously.
【0018】発泡体の気泡形態については独立気泡、連
続気泡、両者の混在のいずれの発泡体も使用可能である
が、水分の揮散性を期待すれば、保温性を妨げない程度
に連続気泡が混在している独立気泡の発泡体が好ましい
。発泡倍率は、5〜55倍の範囲で適宜選択されるが、
本発明における発泡体の使用目的からすると、20〜3
0倍の発泡品が好ましい。Regarding the cell form of the foam, it is possible to use closed cell foam, open cell foam, or a mixture of both, but if moisture volatility is expected, open cell foam may be used to the extent that it does not impede heat retention. A mixed closed cell foam is preferred. The foaming ratio is appropriately selected in the range of 5 to 55 times,
Considering the purpose of use of the foam in the present invention, 20 to 3
A 0x foamed product is preferred.
【0019】(c) 支持体として発泡体層と織布また
は不織布との積層品を用いる場合、発泡体層の片面への
織布または不織布の貼り合わせは、熱ラミネート法、接
着剤法などが適宜採用可能であるが、加熱ラミネート法
が望ましい。(c) When a laminate of a foam layer and a woven or nonwoven fabric is used as a support, the woven or nonwoven fabric can be attached to one side of the foam layer by a thermal lamination method, an adhesive method, or the like. Although it can be used as appropriate, a heating lamination method is preferable.
【0020】2) 膏体 膏体は、粘着剤に薬効成分を含ませて構成されている。2) Plasma The plaster is composed of an adhesive containing medicinal ingredients.
【0021】(a) 粘着剤は膏体のベース成分であり
、親油性(油系)粘着剤および親水性(水系)粘着剤の
中から適宜選択される。(a) The adhesive is the base component of the paste and is appropriately selected from lipophilic (oil-based) adhesives and hydrophilic (water-based) adhesives.
【0022】親油性の粘着剤は一般に温感タイプの貼付
剤に用いられる。親油性の粘着剤としては、スチレン−
イソプレン−スチレンブロック共重合体ゴム、ポリアク
リル酸エステル系重合体、天然ゴム、各種合成ゴムなど
の親油性重合体に、必要に応じて、テルペン系樹脂、脂
環族系合成樹脂、ロジン系樹脂などの粘着付与剤や、流
動パラフィン、ポリブテンなどの軟化剤や、酸化チタン
、酸化亜鉛などの充填剤や、BHTなどの老化防止剤を
配合してなるものが例示される。[0022] Lipophilic adhesives are generally used in warm-sensitive adhesive patches. As a lipophilic adhesive, styrene-
Lipophilic polymers such as isoprene-styrene block copolymer rubber, polyacrylic acid ester polymer, natural rubber, and various synthetic rubbers, as well as terpene resins, alicyclic synthetic resins, and rosin resins, as necessary. Examples include those containing tackifiers such as, softeners such as liquid paraffin and polybutene, fillers such as titanium oxide and zinc oxide, and anti-aging agents such as BHT.
【0023】親水系の粘着剤は一般に冷感タイプの貼付
剤に用いられる。親水性の粘着剤としては、アルギン酸
ナトリウム、ゼラチン、コーンスターチ、トラガントゴ
ム、カゼインなどの天然の水溶性ポリマー;メチルセル
ロース、カルボキシメチルセルロース、ポリビニルアル
コール、ポリアクリル酸ナトリウム、メトキシエチレン
−無水マレイン酸共重合体、ポリビニルエーテルなどの
合成ないし半合成の親水性ポリマーに、必要によりグリ
セリン、プロピレングリコールなどの保湿剤や、水など
の膨潤剤や、アセトン、メチルエチルケトンや、カオリ
ン、ベントナイト、硫酸アルミニウム、酸化亜鉛などを
配合したものが例示される。[0023] Hydrophilic adhesives are generally used in cold-feeling type patches. Hydrophilic adhesives include natural water-soluble polymers such as sodium alginate, gelatin, cornstarch, gum tragacanth, and casein; methylcellulose, carboxymethylcellulose, polyvinyl alcohol, sodium polyacrylate, methoxyethylene-maleic anhydride copolymer, polyvinyl Synthetic or semi-synthetic hydrophilic polymers such as ether are blended with moisturizing agents such as glycerin and propylene glycol, swelling agents such as water, acetone, methyl ethyl ketone, kaolin, bentonite, aluminum sulfate, zinc oxide, etc., if necessary. Things are exemplified.
【0024】(b) 粘着剤に含まれる薬効成分の代表
例として下記のものが挙げられる:
・サルチル酸グリコール、サルチル酸メチルなどのサル
チル酸エステル類、
・トウガラシエキス、ノニル酸ワニリルアミド、カンフ
ル、ハッカ油、メントール、チモール、ビタミンEなど
の外用剤として汎用される薬剤、
・サンシシ、黄柏、カミツレ、アロエ、アルニカなどの
各種生薬、
・インドメタシン、ケトプロフェン、クロルビフロフェ
ンなどの鎮痛消炎剤。(b) Typical examples of medicinal ingredients contained in the adhesive include the following: - Salicylic acid esters such as glycol salicylate and methyl salicylate, - Capsicum extract, nonylic acid vanillylamide, camphor, and peppermint. Drugs commonly used as external preparations such as oil, menthol, thymol, and vitamin E; -Various herbal medicines such as sagebrush, japonica, chamomile, aloe, and arnica; -Analgesic and anti-inflammatory agents such as indomethacin, ketoprofen, and chlorbiflofen.
【0025】膏体中の薬効成分の含有量は好ましくは0
.1〜1.5重量%である。[0025] The content of medicinal ingredients in the paste is preferably 0.
.. It is 1 to 1.5% by weight.
【0026】(c) 膏体は、一般に薬効成分と粘着剤
を所要の割合で慣用の方法たとえばホットメルト法によ
って配合して調製せられる。(c) A plaster is generally prepared by blending a medicinal ingredient and an adhesive in the required proportions by a conventional method, such as a hot melt method.
【0027】3) 支持体への膏体層の形成こうして
薬効成分を粘着剤に含ませてなる膏体層は、ホットメル
ト法、溶剤法、カレンダー法などにより支持体の織布ま
たは不織布側面に、つぎのような手法で設けられる。3) Formation of a plaster layer on the support The plaster layer containing the medicinal ingredient in the adhesive is formed on the side of the woven or non-woven fabric of the support by a hot melt method, a solvent method, a calendar method, etc. , is established using the following method.
【0028】まず、粘着剤をそのまま或いは必要に応じ
てこれに溶剤を加え、これを加温または室温にて粘液状
とし、これに薬効成分を加え全体を均一に混合して膏体
を調製する。ついで、この膏体を塗工機により支持体の
織布または不織布側面に塗布する。このように、膏体を
直接支持体に塗工してもよいし、剥離紙に塗工し、後転
写してもよい。[0028] First, the adhesive is used as it is or a solvent is added thereto as necessary, and this is made into a slimy state by heating or at room temperature, and a medicinal ingredient is added to this and the whole is mixed uniformly to prepare a paste. . Next, this paste is applied to the side surface of the woven or nonwoven fabric of the support using a coating machine. In this way, the paste may be applied directly to the support, or it may be applied to a release paper and then transferred.
【0029】支持体への膏体の塗布形態としては、支持
体の織布または不織布側面に膏体を全面に設けてもよく
、また塗工部を分割するなどして膏体を筋状、網目状、
斑点状などのように塗工部どうしの間に非塗工部を存在
させたパターンで、膏体を部分的に設けてもよい。
膏体を支持体全面に設ける場合には、一般に最終製品に
孔開け加工を施こして、通気性を付与するのが好ましい
。筋状の塗工を行なう場合には、形成した筋の方向が貼
付時に体の筋肉の方向に一致するように塗工を行なうの
が好ましい。As for the form of applying the paste to the support, the paste may be applied to the entire surface of the woven or non-woven fabric side of the support, or the paste may be applied in stripes or by dividing the coated area. mesh,
The plaster may be partially provided in a pattern in which non-coated areas are present between coated areas, such as in spots. When the plaster is provided over the entire surface of the support, it is generally preferable to perforate the final product to impart air permeability. When coating in the form of streaks, it is preferable to apply the coating so that the direction of the formed streaks coincides with the direction of the body's muscles at the time of application.
【0030】最後に、膏体上の全面に剥離紙を貼り合わ
せて膏体層を保護し、得られた製品を所定のシート形状
に裁断し包装する。また、製品を所定のシート形状に裁
断せずにロール巻重体とすることもできる。また、剥離
紙上に膏体を塗布し、これに支持体を貼り合わせること
により製品を得ることもできる。Finally, a release paper is attached to the entire surface of the plaster layer to protect the plaster layer, and the obtained product is cut into a predetermined sheet shape and packaged. Further, the product can be rolled and stacked without cutting it into a predetermined sheet shape. The product can also be obtained by applying a paste onto a release paper and laminating a support thereon.
【0031】膏体層の厚みは一般に100〜350μm
である。[0031] The thickness of the plaster layer is generally 100 to 350 μm.
It is.
【0032】4) 湾曲形状の付与
支持体側を内側にして貼付剤に湾曲形状を付与するには
、たとえばつぎのような方法が行われる。4) Giving a curved shape To give the adhesive patch a curved shape with the support side facing inside, the following method may be used, for example.
【0033】(a) 支持体として発泡体層と織布また
は不織布との積層品を用いる場合、発泡体層を所要強さ
で引っ張っておき織布または不織布には張力を与えない
で、発泡体層の片面へ織布または不織布を貼り合わせる
。発泡体層への織布または不織布の貼り合せは、発泡体
層に炎を軽く当て、表面が溶融した時点でこれに織布ま
たは不織布を貼り合せる方法や、接着剤法などによりな
される。また、熱ロールを用いた熱成形によって支持体
に湾曲形状を与えてもよい。こうして、発泡体層を内側
にして支持体を湾曲させる。(a) When using a laminate of a foam layer and a woven or non-woven fabric as a support, the foam layer is stretched with the required strength and the woven or non-woven fabric is not subjected to any tension. Attach woven or non-woven fabric to one side of the layer. The woven or nonwoven fabric is attached to the foam layer by a method in which the foam layer is lightly exposed to flame and when the surface melts, the woven or nonwoven fabric is attached to it, or by an adhesive method. Alternatively, the support may be given a curved shape by thermoforming using a hot roll. In this way, the support is curved with the foam layer inside.
【0034】(b) 支持体として織布と不織布を用い
る場合、不織布の繊維どうしを結合させるバインダーに
浸漬した不織布、または、たとえばポリエチレンのよう
な低融点の繊維を混抄した不織布に張力を与えながら、
張力を与えない織布に重ね合わせて、この重ね合わせ体
を熱ロールに通過させることにより湾曲形状を付与する
ことができる。また、表層がセルロース、ナイロン、ポ
リエチレンテレフタレートなどのような高融点の繊維か
らなり、裏層が上記低融点の繊維からなる不織布に張力
を与えながら、該裏層を張力を与えない織布と重ね合わ
せ、この重ね合わせ体を熱ロールに通過させることによ
っても湾曲形状を付与することができる。これらの場合
、膏体が塗布もしくは転写されるのは織布面である。(b) When using a woven fabric and a nonwoven fabric as a support, a nonwoven fabric soaked in a binder that binds the fibers of the nonwoven fabric, or a nonwoven fabric mixed with low melting point fibers such as polyethylene, while applying tension. ,
A curved shape can be imparted by overlapping a woven fabric that does not apply tension and passing this overlapping body through a heated roll. In addition, while applying tension to a nonwoven fabric in which the surface layer is made of high melting point fibers such as cellulose, nylon, or polyethylene terephthalate, and the back layer is made of the above-mentioned low melting point fibers, the back layer is overlapped with a woven fabric that does not apply tension. A curved shape can also be imparted by combining and passing this stacked body through a hot roll. In these cases, the plaster is applied or transferred to the fabric surface.
【0035】貼付剤の湾曲率は、貼付剤の幅を(w)と
し、幅の中央における内部高さを(h)とすると(図2
参照)、0.35≧h/w≧0.02の関係が成立する
範囲に設定するのが好ましい。h/wの値が0.35を
超えると貼付剤の肌への馴染み或はフィット感が悪く、
0.02よりも小さいと患部を固定するに充分なコルセ
ット効果が発揮されない。[0035] The curvature of the patch is determined by assuming that the width of the patch is (w) and the internal height at the center of the width is (h) (Figure 2
), it is preferable to set it within a range that satisfies the relationship 0.35≧h/w≧0.02. If the value of h/w exceeds 0.35, the adhesion to the skin or fit of the patch will be poor;
If it is smaller than 0.02, a corset effect sufficient to fix the affected area will not be exhibited.
【0036】[0036]
【作用】本発明による貼付剤は、以上の如く、JIS
L 1005による剛軟度50mm以上および厚み0.
2〜7mmの支持体を備えたものであるので、患部を固
定ないしは支持し得るコルセット効果を発揮するに充分
な剛性を有する。こうして患部を支持ないしは固定する
ことにより、患部が安静にされ、治癒が早められると共
に、使用者も貼付剤に対する適度な違和感により無意識
に無理な動きをすることなく安静に努め、治癒がさらに
早まる。
さらに、この貼付剤は適度な保温効果を発揮するため、
血行が改善され、より充分な治療効果が得られる。また
、貼着力および薬効の点でも申し分がない。[Operation] As described above, the patch according to the present invention meets the JIS standards.
Bending resistance according to L 1005 is 50 mm or more and thickness is 0.
Since it is equipped with a support body of 2 to 7 mm, it has sufficient rigidity to exhibit a corset effect capable of fixing or supporting the affected area. By supporting or fixing the affected area in this way, the affected area is kept at rest and healing is accelerated, and the user also tries to rest without unconsciously making unreasonable movements due to moderate discomfort with the patch, further speeding up the healing. Furthermore, this patch has a moderate heat retention effect, so
Blood circulation is improved and more effective therapeutic effects can be obtained. Moreover, it is satisfactory in terms of adhesive strength and medicinal efficacy.
【0037】また、この貼付剤は支持体側を内側にして
湾曲されているので、貼付剤の肌への馴染みないしはフ
ィット感がよい。[0037] Furthermore, since this patch is curved with the support side inward, the patch has good familiarity or fit to the skin.
【0038】さらにこの湾曲形状によってそれ自体の形
態の保持効果が発揮され、いわゆる腰があって垂れるこ
とのない貼付剤が得られる。したがって、貼付の際に剥
離紙除去後の貼付剤が膏体面を合わせるように折れ曲が
り、膏体面どうしがくっつくという問題がなく、腰痛の
場合でも貼付位置合わせがやり易く、貼付は使用者ひと
りでなし得る。Furthermore, this curved shape exhibits the effect of retaining its own shape, resulting in a patch that has so-called firmness and does not sag. Therefore, there is no problem that the patch after removing the release paper will bend to match the plaster surfaces and the plaster surfaces will stick to each other during application, and it is easy to align the application position even in cases of lower back pain, and the application can be done by the user alone. obtain.
【0039】また、大型のサイズの貼付剤を提供するこ
とも可能である。[0039] It is also possible to provide patches of large size.
【0040】[0040]
【実施例】つぎに、本発明を具体的に説明するために、
本発明の実施例を挙げ、さらに得られた貼付剤の性能評
価を示す。[Example] Next, in order to specifically explain the present invention,
Examples of the present invention will be given, and performance evaluation of the obtained patches will also be shown.
【0041】1) 支持体の調製
発泡倍率が30倍である市販の電子線架橋タイプのポリ
エチレン発泡体(積水化学社製、商品名「セキスイソフ
トロンIF30025」)からなる厚み2.5mmの発
泡体層に、レーヨンとポリエチレングリコールテレフタ
レートの混抄からなる不織布(混抄重量比80対20、
厚み0.25mm、重量70g/m2 の長繊維不織布
)を、熱ラミネート法により貼り合わせた。すなわち、
発泡体層を所要強さで引っ張っておき不織布には張力を
与えないで、発泡体層の片面へ不織布を貼り合わせる。
発泡体層への不織布の貼り合せは、発泡体層に炎を軽く
当て、表面が溶融した時点でこれに不織布を貼り合せる
方法により行なった。1) Preparation of support A 2.5 mm thick foam made of commercially available electron beam cross-linked polyethylene foam (manufactured by Sekisui Chemical Co., Ltd., trade name: "Sekisui Softlon IF30025") with a foaming ratio of 30 times. The layer is a nonwoven fabric made of a mixed paper of rayon and polyethylene glycol terephthalate (mixed paper weight ratio 80:20,
A long fiber nonwoven fabric having a thickness of 0.25 mm and a weight of 70 g/m2 was bonded together by a thermal lamination method. That is,
The nonwoven fabric is pasted onto one side of the foam layer by pulling the foam layer with the required strength and applying no tension to the nonwoven fabric. The nonwoven fabric was attached to the foam layer by a method in which the foam layer was lightly exposed to flame and when the surface melted, the nonwoven fabric was attached to the foam layer.
【0042】こうして、添付の図1および2に示すよう
に、発泡体層(1) を内側にし不織布(2) を外側
にして湾曲した支持体(3) を調製した。先に定義し
たh/wの値は0.15で、JIS L 1005によ
る剛軟度は92mmで、厚み2.3mmで、20%モジ
ュラス1.5kg/25mm幅である。In this way, a curved support (3) was prepared with the foam layer (1) on the inside and the nonwoven fabric (2) on the outside, as shown in the attached FIGS. 1 and 2. The previously defined h/w value is 0.15, the bending resistance according to JIS L 1005 is 92 mm, the thickness is 2.3 mm, and the 20% modulus is 1.5 kg/25 mm width.
【0043】2) 膏体の調製
スチレン−イソプレン−スチレンブロック共重合体10
0重量部、流動パラフィン120重量部、脂環族系樹脂
130重量部、酸化チタン5重量部およびBHT3重量
部からなる粘着剤組成物に、薬効成分としてサンシシ乾
燥エキス1.0重量部および6%トウガラシエキス0.
05重量部を配合し、ホットメルト法にて130〜14
0℃の温度で全体が均一になるように加熱攪拌して、親
油性の膏体を作った。2) Preparation of plaster Styrene-isoprene-styrene block copolymer 10
0 parts by weight, 120 parts by weight of liquid paraffin, 130 parts by weight of alicyclic resin, 5 parts by weight of titanium oxide, and 3 parts by weight of BHT, and 1.0 parts by weight of dried extract of Sanshishi and 6% as medicinal ingredients. Capsicum extract 0.
0.05 parts by weight was blended, and the hot melt method was used to obtain 130 to 14
A lipophilic paste was prepared by heating and stirring at a temperature of 0° C. to make the whole mixture uniform.
【0044】3) 支持体への膏体の塗工まず、片面
にシリコーン層を有するポリエチレングリコールテレフ
タレートフィルムからなる厚み25μmの剥離紙を用意
し、この剥離紙のシリコーン層側に、先に調製した膏体
をホットメルト塗工機で、厚み250μm、塗布幅10
mm、非塗布幅10mmで、支持体の幅方向に平行な多
数の筋状に塗布した。その直後に膏体層がまだ80〜9
0℃の温度を保っている間に、転写法により先に調製し
た支持体(3) の不織布(2) 側に膏体層(4)
を貼り合わせた。3) Coating the paste onto the support First, a 25 μm thick release paper made of polyethylene glycol terephthalate film having a silicone layer on one side was prepared, and on the silicone layer side of this release paper, the previously prepared adhesive was applied. Apply the plaster using a hot melt coating machine to a thickness of 250 μm and a coating width of 10
The coating was applied in a number of stripes parallel to the width direction of the support with an uncoated width of 10 mm. Immediately after that, the plaster layer was still 80-9.
While maintaining the temperature at 0°C, a plaster layer (4) is applied to the nonwoven fabric (2) side of the support (3) previously prepared by the transfer method.
pasted together.
【0045】4) シート化
この貼り合わせ品を縦220mm×横100mmのシー
トに裁断し、最終製品として貼付剤(5) を製造した
。4) Formation into a sheet This bonded product was cut into sheets measuring 220 mm in length and 100 mm in width to produce a patch (5) as a final product.
【0046】5) 性能試験
実施例で得られた貼付剤を腰痛のあるボランティアの複
数の被験者(男子22名、女子7名、年齢37〜57才
)に、凸弧状の膏体層を腰部背面の曲面に沿わせて貼り
付けてもらい、その貼付感触を評価してもらった。5) The patch obtained in the performance test example was applied to multiple volunteer subjects (22 males and 7 females, ages 37 to 57) with lower back pain, and a convex arc-shaped plaster layer was applied to the back of the lower back. The participants were asked to apply it along the curved surface of the screen and evaluate the feel of the application.
【0047】その結果、実施例の貼付剤は極めて貼付し
易く、腰部背面の曲面によくフィットし、快適な使用感
が得られることが認められた。また、この貼付剤は、患
部を固定するコルセット効果、保温効果、貼着力および
薬効の点でも優れていることが認められた。As a result, it was found that the patch of Example was extremely easy to apply, fit well to the curved surface of the back of the lower back, and provided a comfortable feeling of use. Furthermore, this patch was found to be excellent in terms of corset effect for fixing the affected area, heat retention effect, adhesion strength, and medicinal efficacy.
【0048】[0048]
【発明の効果】本発明の貼付剤によれば、支持体として
特定の物性を有するものを用いているので、患部を固定
ないしは支持し得るコルセット効果を発揮させることが
できる。そして、こうして患部を支持ないしは固定する
ことにより、患部を安静にさせ、治癒を早めることがで
きると共に、使用者も貼付剤に対する適度な違和感によ
り無意識に無理な動きをすることなく安静に努め、治癒
をさらに早めることができる。さらに、この貼付剤は適
度な保温効果を発揮するため、血行を改善し、より充分
な治療効果を発揮させることができる。また、貼着力お
よび薬効の点でも申し分がない。Effects of the Invention According to the adhesive patch of the present invention, since a material having specific physical properties is used as a support, a corset effect capable of fixing or supporting the affected area can be exerted. By supporting or fixing the affected area in this way, the affected area can be kept at rest and healing can be accelerated, and the user can also try to rest without unconsciously making forced movements due to the moderate discomfort of the patch, allowing the area to heal. can be further accelerated. Furthermore, since this patch exhibits a moderate heat-retaining effect, it can improve blood circulation and exhibit a more sufficient therapeutic effect. Moreover, it is satisfactory in terms of adhesive strength and medicinal efficacy.
【0049】また、この貼付剤は支持体側を内側にして
湾曲されているので、貼付剤の肌への馴染みないしはフ
ィット感を良好ならしめることができる。[0049] Furthermore, since this adhesive patch is curved with the support side inward, it is possible to improve the familiarity or fit of the adhesive patch to the skin.
【0050】さらにこの湾曲形状によってそれ自体の形
態の保持効果を発揮させ、いわゆる腰があって垂れるこ
とのない貼付剤を得ることができる。したがって、腰痛
の場合でも貼付位置合わせがやり易く、貼付は使用者ひ
とりでなし得る。また、大型のサイズの貼付剤を提供す
ることも可能である。Furthermore, this curved shape exhibits the effect of retaining its own shape, making it possible to obtain a patch that has so-called firmness and does not sag. Therefore, even in the case of lower back pain, it is easy to align the application position, and the application can be done by the user alone. It is also possible to provide patches of large size.
【図1】本発明貼付剤の斜視図である。FIG. 1 is a perspective view of the patch of the present invention.
【図2】図1中のII−II線に沿う断面図である。FIG. 2 is a sectional view taken along line II-II in FIG. 1.
(1) …発泡体層 (2) …不織布 (3) …支持体 (4) …膏体層 (5) …貼付剤 (w) …貼付剤の幅 (h) …内部高さ (1)...Foam layer (2)...Nonwoven fabric (3)...Support (4)...Paste layer (5)...patch (w)...width of patch (h)...Internal height
Claims (1)
層が、JIS L 1005による剛軟度50mm以上
で厚み0.2〜7mmの支持体の片面に設けられ、支持
体側を内側にして湾曲されていることを特徴とする医療
用貼付剤。Claim 1: A plaster layer made of an adhesive containing a medicinal ingredient is provided on one side of a support having a bending resistance of 50 mm or more according to JIS L 1005 and a thickness of 0.2 to 7 mm, with the support side facing inside. A medical patch characterized by being curved.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP06831491A JP3196851B2 (en) | 1991-04-01 | 1991-04-01 | Medical patch |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP06831491A JP3196851B2 (en) | 1991-04-01 | 1991-04-01 | Medical patch |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH04305522A true JPH04305522A (en) | 1992-10-28 |
JP3196851B2 JP3196851B2 (en) | 2001-08-06 |
Family
ID=13370236
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP06831491A Expired - Fee Related JP3196851B2 (en) | 1991-04-01 | 1991-04-01 | Medical patch |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3196851B2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06105857A (en) * | 1992-06-05 | 1994-04-19 | Sekisui Chem Co Ltd | Convenient corset and its sticking body |
JPH09194351A (en) * | 1996-01-18 | 1997-07-29 | Sekisui Chem Co Ltd | Percutaneous patch material |
EP1075827A2 (en) * | 1999-08-12 | 2001-02-14 | Beiersdorf AG | Self-adhesive shaped body |
JP2011016802A (en) * | 2002-06-10 | 2011-01-27 | Euro-Celtique Sa | Disposal system for transdermal delivery device to prevent misuse of active agent contained in the transdermal delivery device |
JP2020014768A (en) * | 2018-07-27 | 2020-01-30 | ピップ株式会社 | Waist supporter |
-
1991
- 1991-04-01 JP JP06831491A patent/JP3196851B2/en not_active Expired - Fee Related
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06105857A (en) * | 1992-06-05 | 1994-04-19 | Sekisui Chem Co Ltd | Convenient corset and its sticking body |
JPH09194351A (en) * | 1996-01-18 | 1997-07-29 | Sekisui Chem Co Ltd | Percutaneous patch material |
EP1075827A2 (en) * | 1999-08-12 | 2001-02-14 | Beiersdorf AG | Self-adhesive shaped body |
EP1075827A3 (en) * | 1999-08-12 | 2002-06-19 | Beiersdorf AG | Self-adhesive shaped body |
JP2011016802A (en) * | 2002-06-10 | 2011-01-27 | Euro-Celtique Sa | Disposal system for transdermal delivery device to prevent misuse of active agent contained in the transdermal delivery device |
JP2020014768A (en) * | 2018-07-27 | 2020-01-30 | ピップ株式会社 | Waist supporter |
CN110772367A (en) * | 2018-07-27 | 2020-02-11 | 蓓福株式会社 | Waist protector |
Also Published As
Publication number | Publication date |
---|---|
JP3196851B2 (en) | 2001-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3442423B2 (en) | Simple corset and simple corset stuck body | |
US7063859B1 (en) | Barrier film lined backing layer composition and method for topical administration of active agents | |
JPS59105407A (en) | Cosmetic tool | |
JPH05309128A (en) | Adhesive plaster and adhesive plaster formulation | |
EP0779064B1 (en) | Surgical dressing | |
NO880552L (en) | POLYMER MATERIALS. | |
JPS63145222A (en) | Cataplasm | |
JPH04305522A (en) | Application agent for medical use | |
JP3002772B2 (en) | Patch and its manufacturing method | |
JPH04308527A (en) | Plaster for medical use | |
JPH09262249A (en) | Hydrogel adhesive plaster | |
JPH03161435A (en) | Cataplasm | |
JP3248764B2 (en) | Patch | |
JP3581863B2 (en) | Patch | |
JP3115627B2 (en) | Medical patch | |
JP2000143503A (en) | Plaster for external use | |
JP3171935B2 (en) | Patch with excellent sticking properties | |
JPH082784B2 (en) | Medical patch | |
JPH08260328A (en) | Elastic nonwoven fabric and substrte for patch using the same | |
JPS6193112A (en) | Plaster | |
JPH08133973A (en) | Plaster containing indomethacin | |
JP2568835Y2 (en) | Patch | |
JP2002282297A (en) | Skin surface warming pasting material | |
JP2531179B2 (en) | Poultice | |
JPH06238784A (en) | Heat-insulating and moisture-absorptive sheet and bonding agent for medical treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313115 |
|
R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
R370 | Written measure of declining of transfer procedure |
Free format text: JAPANESE INTERMEDIATE CODE: R370 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313115 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080608 Year of fee payment: 7 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313115 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080608 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090608 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090608 Year of fee payment: 8 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090608 Year of fee payment: 8 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100608 Year of fee payment: 9 |
|
LAPS | Cancellation because of no payment of annual fees |